0000873303-11-000049.txt : 20111216
0000873303-11-000049.hdr.sgml : 20111216
20111216114809
ACCESSION NUMBER: 0000873303-11-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20111215
FILED AS OF DATE: 20111216
DATE AS OF CHANGE: 20111216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christopher Nishan Garabedian
CENTRAL INDEX KEY: 0001492604
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 111265357
MAIL ADDRESS:
STREET 1: 333 RIVER STREET
STREET 2: #303
CITY: HOBOKEN
STATE: NJ
ZIP: 07030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVI BIOPHARMA INC
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2011-12-15
0
0000873303
AVI BIOPHARMA INC
AVII
0001492604
Christopher Nishan Garabedian
3450 MONTE VILLA PARKWAY, SUITE 101
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2011-12-15
4
P
0
300000
0.5788
A
430000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.56 to $0.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
By: Effie Toshav For: Christopher Nishan Garabedian
2011-12-16
EX-24
2
ex-24.txt
EDGAR SUPPORTING DOCUMENT
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of
AVI BioPharma, Inc. (the Company), hereby
constitutes and appoints each of Bryan King,
Effie Toshav and Wilson Sonsini Goodrich &
Rosati, P.C. the undersigneds true and lawful attorney
in fact to:
1. complete and execute Forms ID, 3,4 and 5
and other forms and all amendments thereto as
such attorney in fact shall in his or her discretion
determine to be required or advisable pursuant
to Section 16 of the Securities Exchange Act of 1934
(as amended) and the rules and regulations
promulgated thereunder, or any successor laws and
regulations, as a consequence of the undersigneds
ownership, acquisition or disposition of securities
of the Company; and
2. do all acts necessary in order to file such
forms with the Securities and Exchange Commission,
any securities exchange or national association,
the Company and such other person or agency as the
attorney in fact shall deem appropriate. The
undersigned hereby ratifies and confirms all that
said attorney in fact and agents shall do or cause
to be done by virtue hereof. The undersigned
acknowledges that each foregoing
attorney in fact, in serving in such capacity
at the request of the undersigned, is not
assuming, nor is the Company assuming, any of
the undersigneds responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934
(as amended).
This Power of Attorney revokes any previously
executed powers of attorney and shall remain in
full force and effect until the undersigned is
no longer required to file Forms ID, 3, 4 and 5
with respect to the undersigneds holdings of and
transactions in securities issued by the
Company, unless earlier revoked by the undersigned
in a signed writing delivered to the
Company and each foregoing attorney in fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 15th
day of December, 2011.
Signature /s/ Christopher Garabedian
Christopher Garabedian